[{"Assets_0_Q1_USD":429109000.0,"CommonStockSharesOutstanding_0_Q1_shares":145365000.0,"EarningsPerShareBasic_1_Q1_USD":0.01,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-4424000.0,"NetIncomeLoss_1_Q1_USD":1796000.0,"StockholdersEquity_0_Q1_USD":260047000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":144743000.0,"Ticker":"HALO","CIK":"1159036","name":"HALOZYME THERAPEUTICS INC","OfficialName":"Halozyme Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5856719603.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]